Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Anti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma Study [NA]
A clinical trial comparing anti-PD-1 therapy with and without a postbiotic in treatment-naïve locally advanced or metastatic cutaneous melan…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders [Phase 2]
A Phase 2 clinical trial at Oslo University Hospital is testing fecal microbiota transplantation from clinical responders in cancer patients…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)
A recruiting clinical study from University Health Network evaluating a non-invasive AI-based platform for patient monitoring, named NIP IT!…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Using QPOP to Predict Treatment for Sarcomas and Melanomas
A recruiting clinical study from the National Cancer Centre, Singapore evaluating the QPOP method to predict effective treatments for patien…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Study to Investigate LYL845 in Adults With Solid Tumors [Phase 1]
Lyell Immunopharma reports termination of the Phase 1 trial evaluating LYL845 in adults with solid tumors, including melanoma, non-small cel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Preoperative Planning With PSMA-PET in Melanoma Surgery Trial [Phase 2]
Phase 2 clinical trial evaluating PSMA-PET imaging to assist preoperative planning in melanoma surgery is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma [Phase 1]
Phase 1 trial of dendritic cell vaccine therapy for advanced melanoma has completed.
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma [Phase 2]
This document describes a Phase II clinical trial evaluating a PD-L1 inhibitor in combination with anti-VEGF therapy for unresectable or met…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Symptom Management for YA Cancer Survivors [NA]
A completed clinical trial (NCT04035447) examining symptom management for young adult cancer survivors with results posted in 2025.
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo) [Phase 2]
Phase 2 clinical trial assessing prophylactic mesalamine to prevent colitis after treatment with ipilimumab and nivolumab in patients with a…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Assessment of Safety and Efficacy of OPM-101 Combined With Anti-PD-1 in Patients With Advanced Melanoma Showing Resistance to Anti-PD-1 [Phase 1, Phase 2]
An update on a Phase 1/2 study evaluating the safety and efficacy of OPM-101 combined with anti-PD-1 in advanced melanoma that has shown res…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma [Phase 2]
A Phase 2 clinical trial is evaluating whether sulforaphane, a compound found in cruciferous vegetables, can help prevent melanoma in patien…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Evaluate the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocyte in Patients With Refractory Melanoma Who Failed to Immune Checkpoint Inhibitors [NA]
A clinical trial update investigating autologous tumor-infiltrating lymphocyte therapy for melanoma patients who failed immune checkpoint in…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy [Phase 2]
This Phase 2 study investigates adaptive dosing of the combination of ipilimumab and nivolumab for metastatic melanoma and is currently acti…
-
CLINICAL_TRIALS other · 2025-06-25Clinical Trial Update: FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER) [Phase 1]
A Phase 1 dose-escalation trial of Lu-177-labeled PNT6555 (FRONTIER) for selected solid tumors assessing safety, tolerability and dosimetry;…
-
EMA approval · 2025-06-24EMA Authorised: Cotellic (cobimetinib hemifumarate) — Roche Registration GmbH
EMA authorised Cotellic (cobimetinib hemifumarate) for melanoma; the marketing authorisation holder is Roche Registration GmbH with a decisi…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: APA (Adapted Physical Activity) for Patients With Advanced Melanoma
A clinical trial is recruiting to assess Adapted Physical Activity for patients with advanced melanoma.
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: Education for Prevention of Melanoma in Hispanic Populations [Phase 2]
A Phase 2 trial focusing on education for melanoma prevention in Hispanic populations was terminated; the document does not report results.
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers [Phase 1, Phase 2]
A Phase 1/2 study of BMS-986253 in combination with nivolumab or nivolumab plus ipilimumab in advanced cancers has completed and posted resu…
-
EMA approval · 2025-06-19EMA Authorised: Zelboraf (vemurafenib) — Roche Registration GmbH
The European Medicines Agency authorised Zelboraf (vemurafenib) by Roche Registration GmbH for melanoma.
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors [Phase 2]
A Phase 2 clinical trial by Iovance Biotherapeutics evaluating autologous tumor-infiltrating lymphocytes in solid tumors is currently recrui…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: A Phase 1/2 Study of BA3071 in Patients With Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of BA3071 in patients with solid tumors, including non-small cell lung cancer and mel…
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands [Phase 1]
Phase 1 clinical trial update of LGK974, a Wnt pathway inhibitor, in malignancies dependent on Wnt ligands; the study included several cance…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports results for dendritic cell therapy combined with pembrolizumab in metastatic or unresectable melan…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Glutamate Excitotoxicity in Brain Metastases From Lung, Breast and Melanoma Treated With Stereotactic Radiosurgery
ClinicalTrials.gov entry for a study on glutamate excitotoxicity in brain metastases from lung cancer, breast cancer, and melanoma treated w…